Roberto Murialdo - Publications

A phase III randomized clinical trial of Gemcitabine and Nab-Paclitaxel as switch maintenance versus continuation of modified FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: The PANThEON Study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: September 13, 2025

Streamlining the diagnostic pathway for Lynch syndrome in colorectal cancer patients: a 10-year experience in a single Italian Cancer Center.

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)

Published: January 08, 2024

The Multidisciplinary Approach of Rectal Cancer: The Experience of "COMRE Group" Model.

Journal: Diagnostics (Basel, Switzerland)

Published: April 14, 2022

Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial.

Journal: International journal of cancer

Published: March 28, 2022

Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study.

Journal: Journal of translational medicine

Published: January 12, 2022

Effect of Geriatric Comanagement in Older Patients Undergoing Surgery for Gastrointestinal Cancer: A Retrospective, Before-and-After Study.

Journal: Journal of the American Medical Directors Association

Published: November 03, 2021

Safety and Feasibility of Fasting-Mimicking Diet and Effects on Nutritional Status and Circulating Metabolic and Inflammatory Factors in Cancer Patients Undergoing Active Treatment.

Journal: Cancers

Published: July 12, 2021

Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino study.

Journal: British journal of cancer

Published: June 30, 2021

Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino study.

Journal: ESMO open

Published: June 23, 2021

Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study.

Journal: The oncologist

Published: June 15, 2021

TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study.

Journal: Cancers

Published: May 13, 2021

Diversity of Cardiologic Issues in a Contemporary Cohort of Women With Breast Cancer.

Journal: Frontiers in cardiovascular medicine

Published: January 17, 2021